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===========================================================================

In the original publication, there was a minor mistake in one of the figures and a number of reference citation numbers were incorrectly published. The figure and citations are corrected here:

**Page 5/16---Fig. 4**

The reference of Fig. [4](#Fig4){ref-type="fig"} is Dang et al. \[20\] instead Parola et al. \[19\].Fig. 4Effect of OM-85 on IFN-β production at different concentrations (40 to 640 mcg/ml). The increase on IFN-beta production correspond with the increasing concentration of OM-85. \*\*\**p* ≤ 0.001. These in vitro results represent mean ± SD (*n* = 3 techinal replicates). Reference: Dang et al. \[20\]

**Page 5/16---Downregulation in chronic inflammatory state**

The sentence *"by decreasing the levels of proinflammatory cytokines (e.g. interleukin \[IL\]-1b) in a dose-dependent manner* \[24\]" should be referenced by Dang et al. \[20\] instead of \[24\].

**Page 6/16---Fig. 5**

The x axis title on the right side bar in the Fig. [5](#Fig5){ref-type="fig"} should correspond to 10 day post infection and not 5.Fig. 5Effect of OM-85 against viral infections in an in vivo infection model. The viral load in lung tissue was determined on day 5 and 10 post-influenza virus infection. Data are representative of 2--5 experiments with 5--10 mice per time point. Error bars represent minimum to maximum value range. Statistical analysis was performed by Student's *t* test. \*\*\**p* \< 0.001. Reference: Pasquali et al. \[21\]

**Page 6/16---Downregulation in Chronic Inflammatory State**The sentence "and increasing the levels of anti-inflammatory cytokines (e.g. IL-10) \[20\], thus reducing tissue damage" should be referenced by Parola et al. \[19\] instead of Dang et al. \[20\].In the sentence, "OM-85 may also aid maturation of the immune system in children by correcting Th1/Th2 imbalance through increasing Th1 cytokines (IFN-γ) increasing Treg cytokines (IL-10) and decreasing Th2 cytokines (IL-4, IL-5, IL-13) \[18, 24\].", reference Esposito et al. 2018 \[16\] should be added.

**Page 7/16---Efficacy of OM-85 in Children**The sentence, "In children affected by rRTIs in a randomised, double-blind, placebo-controlled study, the proportion of RTI-free patients (the primary endpoint) was significantly higher in the OM-85-treated group compared with the placebo group (see Fig. 7) with total infections 35% lower with OM-85 versus placebo in all children in the study and 28% lower in children aged\\6 years \[33\]." should be referenced by Paupe. Respiration 1991.\[29\] instead of \[33\].The sentence "OM-85 has also been associated with fewer RTIs than placebo (143 versus 299; difference of 52%; p\\0.001; primary endpoint) at 6 months in a randomised, double-blind, placebo-controlled study in girls aged 6--13 years \[35\]. OM-85 also reduced the number of infections in each patient from 494 to 143, with placebo reducing the number of infections from 509 to 299 (p\\0.001, for both comparisons) \[35\]. There were fewer infections at each month with OM-85 compared with placebo (p\\0.05, at months 2, 3, 4 and 6) \[35\]. OM-85 has also been reported to reduce antibiotic use, time to cure and school absenteeism; see Fig. 8 \[35\]." Should be referenced by Jara-Perez et al. \[31\] instead of \[35\].The sentences "OM-85 was also shown to significantly reduce the number and duration of acute RTIs (primary endpoint), with 131 acute RTIs in paediatric patients who received OM-85 compared with 224 in those who received placebo in a randomised, double-blind, placebo-controlled study \[36\]". And "The mean RTIs per patient were significantly lower with OM-85 at 12 months: 5.0 vs. 8.0 (p\\0.001), 38% lower (all patients) and 4.9 vs. 8.3 (p\\0.01), 41% lower (patients aged under 6 years). The total duration of acute RTIs was significantly lower with OM-85 compared with placebo: median 30.5 vs. 55.0 days (p\\0.001), 45% lower (all patients). A higher proportion of children (57% higher; p\\0.001) without recurrences (fewer than six acute RTIs) and less antibiotic consumption (44% less; p\\0.001) was also reported with OM-85 \[36\]". Should be referenced by Gutierrez-Tarango et al. \[32\] instead of \[36\].

**Page 8/16---Efficacy of OM-85 in Children**The sentence, "In the meta-analysis published by Schaad, a 35.5% decrease in the overall mean number of paediatric acute RTIs was demonstrated with OM-85 compared with placebo \[37\]." Should be referenced by Schaad et al. 2010 \[33\] instead of \[37\].The sentence "This was confirmed in 2012 in an updated meta-analysis in 852 children performed by the Cochrane collaboration group in which the immunomodulatory OM-85 was shown to significantly reduce total acute RTIs by 35.9% \[38\]." should be referenced by De-Rio-Navarro et al. 2012 \[34\] instead of \[38\].

**Page 9/16---Concomitant Use of OM-85 and Inactivated Influenza Vaccine /OM-85 and Virus-Induced Wheezing**3."Follow-up for 14 days after vaccination with IIV given with or without OM-85 showed that OM-85 administered with IIV was well tolerated in the short term \[39\]." Should be referenced by Esposito et al. 2015 \[35\] instead of \[39\].4."The impact of treatment observed after 3 months was maintained for 12 months after the prescription, which shows OM-85 prevents wheezing attacks in young children \[40\]." should be referenced by Razi et al. 2010 \[36\] instead of \[40\].

**Page 10/16---Recurrent Acute Otitis Media**"Although only a small number of cases of otitis media were reported in the children in two randomised, placebo-controlled studies (8/99 and 25/100 \[35\] and 3/26 and 14/28 \[36\] in the OM-85 and placebo groups, respectively),..." should be referenced by Jara-Perez et al. 2000 \[31\] and Gutierrez-Tarango et al. 2001 \[32\] respectively, instead of \[35\] and \[36\]

**Page 11/16---Chronic Rhinosinusitis / Acute Tonsillitis**"In a randomised, double-blind, placebo-controlled trial including 55 children aged 4--12 years with acute exacerbation of CRS, OM-85 significantly decreased the number (by 65%) and the total duration (by 64%) of acute episodes after 6 months compared with placebo \[27\]." Should be referenced by Zagar 1988 \[25\] instead of \[27\]."After a median of 9 months' follow-up, no tonsillectomy was required in \[ 50% of treated patients \[47\]." Should be referenced by Bitar 2013 \[44\] instead of \[47\]."A total of 75.6% patients treated and followed up responded to treatment \[total response (no new episodes or recurrent tonsillitis), 51.2%; partial response (reduced re-exacerbation), 24.4%\]" the "\]" at the end of the sentence should be removed.

**Page 12/16---Safety and Tolerability of OM-85 / Discussions and conclusions**"OM-85 was also well tolerated when administered in combination with IIV, did not interfere with antibody titres of vaccine and had no observed effect on humoral immunity \[39\]." Should be referenced by references \[35, 38, 39\] instead of \[39\] only."Meta-analysis of studies with available databases indicate that immunomodulators are not very effective in the prevention of an occasional acute RTI but are in the prevention of recurrent infection \[37, 38, 46\]." References should be \[33, 34, 46\] instead of \[37, 38, 46\].
